Anthropic AI for Science Program Expands to Rare Disease Research

Anthropic is offering grants of up to $50,000 in Claude credits over six months for researchers focusing on rare genetic diseases. This initiative aims to foster a community and accelerate discovery by applying AI to understand disease mechanisms and improve clinical development.

The program features two tracks: one for basic science researchers collaborating with clinical experts and patient organizations, and another for early-stage biotechs focused on speeding up drug development for rare diseases.

AI is expected to help model rare genetic diseases, detect cross-disease patterns, synthesize literature, extract information from limited datasets, and create shared terminology. This can address challenges like limited scientific knowledge, fragmented patient data, and the lengthy drug development process.

Track one partners with the Monarch Initiative, encouraging grantees to use and contribute to resources like the Mondo Disease Ontology and DisMech library. This collaboration aims to improve data interoperability and identify new mechanistic hypotheses for rare diseases.

Track two supports biotechs in compressing drug development timelines by using Claude for tasks such as drafting regulatory documentation, selecting therapeutic strategies, and identifying shared mechanisms for potential 'basket trials'.

Applications are open until August 2, 2026, with accepted projects able to use Claude Opus or other generally available models for their research. Exemptions may be available for projects that might trigger bio classifiers.